BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

476 related articles for article (PubMed ID: 15958636)

  • 21. [Monitoring bcr-abl mRNA levels by real-time quantitative RT-PCR in chronic myeloid leukemia patients after hematopoietic stem cell transplantation].
    Qin YZ; Li JL; Zhu HH; Ruan GR; Li LD; Zhang Y; Xu LP; Liu DH; Liu YR; Huang XJ; Chen SS; Lu DP
    Zhonghua Xue Ye Xue Za Zhi; 2006 Aug; 27(8):511-4. PubMed ID: 17172121
    [TBL] [Abstract][Full Text] [Related]  

  • 22. C/EBPdelta expression in a BCR-ABL-positive cell line induces growth arrest and myeloid differentiation.
    Gery S; Tanosaki S; Hofmann WK; Koppel A; Koeffler HP
    Oncogene; 2005 Feb; 24(9):1589-97. PubMed ID: 15674331
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Abnormal expression of the programmed cell death 5 gene in acute and chronic myeloid leukemia.
    Ruan GR; Qin YZ; Chen SS; Li JL; Ma X; Chang Y; Wang YZ; Fu JY; Liu YR
    Leuk Res; 2006 Sep; 30(9):1159-65. PubMed ID: 16507320
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bcr-Abl expression levels determine the rate of development of resistance to imatinib mesylate in chronic myeloid leukemia.
    Barnes DJ; Palaiologou D; Panousopoulou E; Schultheis B; Yong AS; Wong A; Pattacini L; Goldman JM; Melo JV
    Cancer Res; 2005 Oct; 65(19):8912-9. PubMed ID: 16204063
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The immunophenotype of blast transformation of chronic myelogenous leukemia: a high frequency of mixed lineage phenotype in "lymphoid" blasts and A comparison of morphologic, immunophenotypic, and molecular findings.
    Khalidi HS; Brynes RK; Medeiros LJ; Chang KL; Slovak ML; Snyder DS; Arber DA
    Mod Pathol; 1998 Dec; 11(12):1211-21. PubMed ID: 9872654
    [TBL] [Abstract][Full Text] [Related]  

  • 26. t(8;21)(q22;q22) in blast phase of chronic myelogenous leukemia.
    Yin CC; Medeiros LJ; Glassman AB; Lin P
    Am J Clin Pathol; 2004 Jun; 121(6):836-42. PubMed ID: 15198355
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of the antiapoptotic gene survivin in chronic myeloid leukemia.
    Badran A; Yoshida A; Wano Y; Imamura S; Kawai Y; Tsutani H; Inuzuka M; Ueda T
    Anticancer Res; 2003; 23(1B):589-92. PubMed ID: 12680151
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunological classification of chronic myeloid leukemia distinguishes chronic phase, imminent blastic transformation, and acute lymphoblastic leukemia.
    Schmetzer HM; Gerhartz HH
    Exp Hematol; 1997 Jun; 25(6):502-8. PubMed ID: 9197328
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of glycosylphosphatidylinositol specific phospholipase D gene expression levels on complement mediated killing of leukemic cells in patients with chronic myeloid leukemia.
    Jian-Hua T; Xiao-Jie Z; Yi-Dan W; Wen-Kai L; Wang-Jiao H; Cheng-Hong W; Gui-Yuan L
    Clin Chim Acta; 2005 Sep; 359(1-2):115-24. PubMed ID: 15907827
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chronic myeloid leukemia: correlation between purine metabolism enzyme activities and membrane immunophenotype.
    Mesárosová A; Hrivnáková A; Klobusická M; Babusíková O
    Neoplasma; 1995; 42(1):9-14. PubMed ID: 7617076
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of programmed cell death proteins in patients with chronic myeloid leukemia.
    Strnad M; Brajuskovic G; Strelic N; Todoric-Zivanovic B; Stamatovic D; Tatomirovic Z; Magic Z
    J BUON; 2008; 13(3):403-8. PubMed ID: 18979557
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antibody-producing human-human hybridomas. III. Derivation and characterization of two antibodies with specificity for human myeloid cells.
    Andreasen RB; Olsson L
    J Immunol; 1986 Aug; 137(3):1083-90. PubMed ID: 3459756
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Study on mismatch repair genes of chronic myeloid leukemia].
    Luo J; Peng ZG; Chen Y; Lai YR; Lu YY; Song SJ
    Zhonghua Xue Ye Xue Za Zhi; 2006 Feb; 27(2):103-6. PubMed ID: 16732964
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Persistence of non clonal hematopoietic progenitor cells in blastic phase chronic myelogenous leukemia (CML). Working Party on Severe Aplastic Anemia (WPSAA) of the European Group of Bone Marrow Transplantation (EBMT).
    Martinelli G; Lemoli RM; Farabegoli P; Zaccaria A; Testoni N; Buzzi M; Fogli M; Visani G; Tosi P; Motta MR
    Haematologica; 1994; 79(5):445-7. PubMed ID: 7531170
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Graft-versus-host reaction spares normal stem cells in chronic myelogenous leukemia.
    Kolb HJ; Mittermüller J; Holler E; Thalmeier K; Bartram CR
    Bone Marrow Transplant; 1996 Mar; 17(3):449-52. PubMed ID: 8704705
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Detection of phosphotyrosine in bcr-abl-positive cells with PY20 antibody and its clinical applications].
    Zhu HH; Liu YR; Qin YZ; Chang Y; Li JL; Ruan GR; Jiang B; Chen SS; Lu DP
    Zhonghua Xue Ye Xue Za Zhi; 2006 Jul; 27(7):441-4. PubMed ID: 17147244
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Behavior in vitro of long-term cultured bone marrow or blood cells from chronic myeloid leukemia: adhesion molecules and differentiation antigens as detected by immunocytochemistry.
    Pasternak G; Pasternak L
    Folia Biol (Praha); 1994; 40(6):439-54. PubMed ID: 7589702
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of bone marrow high mitotic index metaphase fluorescence in situ hybridization to peripheral blood and bone marrow real time quantitative polymerase chain reaction on the International Scale for detecting residual disease in chronic myeloid leukemia.
    Lundán T; Juvonen V; Mueller MC; Mustjoki S; Lakkala T; Kairisto V; Hochhaus A; Knuutila S; Porkka K
    Haematologica; 2008 Feb; 93(2):178-85. PubMed ID: 18223279
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Instability of BCR-ABL gene in primary and cultured chronic myeloid leukemia stem cells.
    Jiang X; Saw KM; Eaves A; Eaves C
    J Natl Cancer Inst; 2007 May; 99(9):680-93. PubMed ID: 17470736
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Alternative BCR/ABL splice variants in Philadelphia chromosome-positive leukemias result in novel tumor-specific fusion proteins that may represent potential targets for immunotherapy approaches.
    Volpe G; Cignetti A; Panuzzo C; Kuka M; Vitaggio K; Brancaccio M; Perrone G; Rinaldi M; Prato G; Fava M; Geuna M; Pautasso M; Casnici C; Signori E; Tonon G; Tarone G; Marelli O; Fazio VM; Saglio G
    Cancer Res; 2007 Jun; 67(11):5300-7. PubMed ID: 17545610
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.